Linkedin
+1 305 374 2500
contact@brandinstitute.com
Panel Members
Home
About
DSI Experts
RX Market Share
Solutions
Experience
Press Room
Contact
Brand Insights
Clearing a Global Pharmaceutical Trademark
Hurdles to Overcome When Developing a Brand Name
Preserving Patient Safety: Understanding the Risks of Look-Alike and Sound-Alike Drug Names
The Value of Consumer Brand Name Market Research
The Crucial Role of Linguistic Appropriateness in Branding
The Importance of a Drug Name from a European Perspective
Developing a Pharmaceutical Brand Name for the Japanese Market? Here’s What You Need to Know
The Canadian Regulatory Landscape for Pharmaceutical Brand Naming
The Importance of Timing in Pharmaceutical Brand Naming
The Importance of a Well-Designed Corporate Logo
ANVISA: The Most Mature Pharmaceutical Regulatory System in Latin America
In 2023, One Brand Name Development Strategy is Rising to the Forefront
Branded Generics: Differentiating Your Generic Drug Product with a Strong Brand Name
From Letters to Language: The Evolution of Clinical Trial Naming Conventions
Why Guess When You Can Test? The Importance of Market Research in Pharmaceutical Brand Naming
Two Brands, One Drug: The Potential Benefits and Challenges of Dual Branding
Building a Reputation of Excellence: Brand Institute’s Journey
The Power of Trademark Analytic Data in Crafting Effective Brand Names
Biosimilar Naming: Balancing Competition and Compliance
Brand Name Approvals for Medicinal Products in the European Union: A Vital Part of Drug Safety
The Rise of the Letter Y in Pharmaceutical Brand Naming
A Suffix Like No Other – Navigating the Nonproprietary Naming of Biological Products
Naming Strategies in Pharmaceutical Brand Name Development
Standing Out in the Nonproprietary Naming Arena
